Abeona Therapeutics Incの浮動株式数
Abeona Therapeutics Incの浮動株式数は何ですか。
Abeona Therapeutics Incの浮動株式数は0.000 0.00%です。
浮動株式数の定義は何ですか。
浮動株式数は、ロックインされた株式とは対照的に、公的投資家の手にある企業の株式の一部です。
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
NASDAQのセクタHealth Careにおける浮動株式数の企業と比べるAbeona Therapeutics Inc
Abeona Therapeutics Incは何をしますか。
abeona therapeutics inc. (nasdaq: $abeo), is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases. abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases. abeona's lead programs include abo-102 (aav-sgsh), an adeno-associated virus (aav) based gene therapy for sanfilippo syndrome type a (mps iiia) and eb-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (rdeb). abeona is also developing abo-101 (aav-naglu) for sanfilippo syndrome type b (mps iiib), abo-201 (aav-cln3) gene therapy for juvenile batten disease (jncl), abo-202 (aav-cln1) for treatment of infantile batten disease (incl), eb-201 for epidermolysis bullosa (eb), abo-301 (aav-fancc) for fanconi anemia (fa) disorder and abo-302 using a novel crispr/cas9-based gene editing approach to gene t
Abeona Therapeutics Incと類似の浮動株式数
- NUGLの浮動株式数は-299.800M -652.83%です。
- JB&ZJMY Coの浮動株式数は-20.250M -294238.80%です。
- Epicの浮動株式数は-2.451M -11.73%です。
- Abeona Therapeutics Incの浮動株式数は0.000 0.00%です。
- La Fonciere Verteの浮動株式数は10.000 0.00%です。
- Media Lab S.p.Aの浮動株式数は142.000 0.01%です。
- Hydraulique P.B Societe anonymeの浮動株式数は400.000 0.57%です。
- Societe Anonyme Immobilier Parisienne De La Perle Et Des Pierres Precieusesの浮動株式数は1.003kです。
- Harmony Acquisitions Corpの浮動株式数は1.301k 0.02%です。
- Carbon Mineralsの浮動株式数は2.068k 0.01%です。